CORD-19:3f9572ae671d876279b4d2cd6b6544b24fb3e52d / 29215-29502 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T165","span":{"begin":0,"end":287},"obj":"Sentence"},{"id":"TextSentencer_T165","span":{"begin":0,"end":287},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Since it was initially identified as a downregulated mRNA in metastatic breast tumor cells compared to normal and primary breast tumor cells 82 , it is likely that the loss of the expression of cystatin E/M is associated with the progression of a primary tumor to a metastatic phenotype."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T69","span":{"begin":72,"end":84},"obj":"Phenotype"},{"id":"T70","span":{"begin":122,"end":134},"obj":"Phenotype"},{"id":"T71","span":{"begin":255,"end":260},"obj":"Phenotype"}],"attributes":[{"id":"A69","pred":"hp_id","subj":"T69","obj":"http://purl.obolibrary.org/obo/HP_0100013"},{"id":"A70","pred":"hp_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/HP_0100013"},{"id":"A71","pred":"hp_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"Since it was initially identified as a downregulated mRNA in metastatic breast tumor cells compared to normal and primary breast tumor cells 82 , it is likely that the loss of the expression of cystatin E/M is associated with the progression of a primary tumor to a metastatic phenotype."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T70","span":{"begin":72,"end":78},"obj":"Body_part"},{"id":"T71","span":{"begin":122,"end":128},"obj":"Body_part"}],"attributes":[{"id":"A70","pred":"uberon_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"},{"id":"A71","pred":"uberon_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"Since it was initially identified as a downregulated mRNA in metastatic breast tumor cells compared to normal and primary breast tumor cells 82 , it is likely that the loss of the expression of cystatin E/M is associated with the progression of a primary tumor to a metastatic phenotype."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T121","span":{"begin":72,"end":84},"obj":"Disease"},{"id":"T123","span":{"begin":79,"end":84},"obj":"Disease"},{"id":"T124","span":{"begin":122,"end":134},"obj":"Disease"},{"id":"T126","span":{"begin":129,"end":134},"obj":"Disease"},{"id":"T127","span":{"begin":255,"end":260},"obj":"Disease"},{"id":"T87011","span":{"begin":72,"end":84},"obj":"Disease"},{"id":"T93367","span":{"begin":79,"end":84},"obj":"Disease"},{"id":"T81773","span":{"begin":122,"end":134},"obj":"Disease"},{"id":"T30786","span":{"begin":129,"end":134},"obj":"Disease"},{"id":"T6816","span":{"begin":255,"end":260},"obj":"Disease"}],"attributes":[{"id":"A121","pred":"mondo_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A122","pred":"mondo_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/MONDO_0021100"},{"id":"A123","pred":"mondo_id","subj":"T123","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A124","pred":"mondo_id","subj":"T124","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A125","pred":"mondo_id","subj":"T124","obj":"http://purl.obolibrary.org/obo/MONDO_0021100"},{"id":"A126","pred":"mondo_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A127","pred":"mondo_id","subj":"T127","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A23911","pred":"mondo_id","subj":"T87011","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A24025","pred":"mondo_id","subj":"T87011","obj":"http://purl.obolibrary.org/obo/MONDO_0021100"},{"id":"A76747","pred":"mondo_id","subj":"T93367","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A56770","pred":"mondo_id","subj":"T81773","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A72803","pred":"mondo_id","subj":"T81773","obj":"http://purl.obolibrary.org/obo/MONDO_0021100"},{"id":"A44390","pred":"mondo_id","subj":"T30786","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A76497","pred":"mondo_id","subj":"T6816","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"Since it was initially identified as a downregulated mRNA in metastatic breast tumor cells compared to normal and primary breast tumor cells 82 , it is likely that the loss of the expression of cystatin E/M is associated with the progression of a primary tumor to a metastatic phenotype."}